Single-Row Versus Double-Row Repair for Achilles Insertional Tendinopathy
NCT ID: NCT07323875
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
166 participants
INTERVENTIONAL
2026-02-28
2030-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome After Surgical Reconstruction of the Achilles Tendon Insertion.
NCT06030908
Reinsertion Achilles Tendon VS Zadek Osteotomy in Insertional Achilles Tendinopathy
NCT06322381
The Effect of Collagen Scaffold Augmentation in Achilles Tendon Rupture Repair
NCT07130357
A Randomized Trial to Evaluate the Effectiveness of Transferring the Flexor Hallucis Longus Tendon
NCT01341509
The Effect of High Volume Injection With and Without Steroid in Chronic Achilles Tendinopathy
NCT02839577
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This multi-center randomized controlled trial will use the disease-specific Victorian Institute of Sports Assessment-Achilles (VISA-A) score to compare clinical outcomes between single-row and double-row repairs, providing high-quality evidence to guide optimal surgical management.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single-row repair Arm
Single-row repair will involve 2 suture anchors (2 anchors total)
Single-row repair of the Achilles tendon at its calcaneal insertion
single-row (2 anchors)
Double-row repair Arm
Double-row repair will involve 2 suture anchors for the proximal row and 2 suture anchors for the distal row (4 anchors total)
Double-row repair of the Achilles tendon at its calcaneal insertion
double-row (4 anchors)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Single-row repair of the Achilles tendon at its calcaneal insertion
single-row (2 anchors)
Double-row repair of the Achilles tendon at its calcaneal insertion
double-row (4 anchors)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Must sign and date the informed consent form;
3. Stated willingness to comply with all study procedures;
4. Adult patients between the ages of 18 and 75 years with symptomatic chronic Achilles insertional tendinopathy for a minimum of 3 months
5. Failure of non-operative management (which includes physiotherapy, stretching exercises, heel lifts, nonsteroidal anti-inflammatory drugs (NSAIDs), activity modification, etc.) for at least 3 months.
6. Preoperative imaging (x-ray and Medical Resonance Imaging (MRI)) is available and completed;
7. Willingness of patients to follow the postoperative rehabilitation protocol;
8. Willingness of patients to be available for follow up appointments for up to 2 years.
Exclusion Criteria
2. Achilles tendon rupture;
3. Previous Achilles tendon surgery;
4. Oral steroid use or steroid injection within 3 months of surgery;
5. History of connective tissue or collagen disorder (e.g. Marfan Syndrome)
6. History of chronic inflammatory disorders
7. History of neurological disease (stroke, cerebral palsy)
8. History of using more than 30mg of oxycodone or equivalent per day;
9. Current cigarette smoker (Former smokers must have quit for minimum of one year)
10. Diabetes type I or II
11. Pregnancy
12. Hypersensitivity to metal, Polylactic Acid (PLA), or Polyetheretherketone (PEEK) materials
13. Active infection
14. Worker's compensation claim (e.g. WSIB)
15. History of cognitive or mental health conditions that would make the participant unable to complete study procedures
16. Non-English speaking
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Physicians' Services Incorporated Foundation
OTHER
University Health Network, Toronto
OTHER
Unity Health Toronto
OTHER
University of Toronto
OTHER
Women's College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sam Park
MD MASc FRCPC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Si-Hyeong Sam Park, MD, FRCPC
Role: PRINCIPAL_INVESTIGATOR
Women's College Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Women's College Hospital
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTO Study Number:5686
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.